Citigroup’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.07M Buy
322,745
+178,144
+123% +$5.02M 0.01% 1604
2025
Q4
$4.55M Buy
144,601
+15,716
+12% +$521K ﹤0.01% 2080
2025
Q3
$4.6M Buy
128,885
+45,979
+55% +$2.1M ﹤0.01% 2025
2025
Q2
$4.78M Sell
82,906
-20,000
-19% -$1.13M ﹤0.01% 1928
2025
Q1
$6M Buy
102,906
+60,009
+140% +$4.1M ﹤0.01% 1744
2024
Q4
$3.45M Buy
42,897
+6,821
+19% +$583K ﹤0.01% 2324
2024
Q3
$2.89M Buy
36,076
+22,483
+165% +$1.6M ﹤0.01% 2343
2024
Q2
$830K Buy
13,593
+2,750
+25% +$164K ﹤0.01% 3042
2024
Q1
$536K Buy
10,843
+972
+10% +$46.3K ﹤0.01% 3519
2023
Q4
$414K Buy
9,871
+3,954
+67% +$135K ﹤0.01% 3543
2023
Q3
$194K Sell
5,917
-14,773
-71% -$504K ﹤0.01% 3670
2023
Q2
$731K Buy
20,690
+13,793
+200% +$456K ﹤0.01% 3080
2023
Q1
$196K Buy
6,897
+1,644
+31% +$58K ﹤0.01% 3750
2022
Q4
$218K Sell
5,253
-1,533
-23% -$65.8K ﹤0.01% 3672
2022
Q3
$281K Buy
6,786
+3,500
+107% +$140K ﹤0.01% 3595
2022
Q2
$107K Buy
3,286
+2,929
+820% +$107K ﹤0.01% 4191
2022
Q1
$12K Sell
357
-1,563
-81% -$37.6K ﹤0.01% 5438
2021
Q4
$48K Buy
+1,920
New +$71K ﹤0.01% 5085

Other funds holding PRCT